Prevalence of HIV among adults aged 15 to 49 in Uruguay
Uruguay: Prevalence of HIV among adults aged 15 to 49 was 0.6% in 2025. ▲ Rising
Prevalence of HIV among adults aged 15 to 49 in Uruguay, 2000–2025
Source: World Health Organization, Global Health Observatory.
Analysis
The most recent figure for prevalence of hiv among adults aged 15 to 49 in Uruguay is 0.6%, measured in 2025. That is the highest value across all 26 years on record.
The figure is up 20.0% over ten years.
Over the whole period, prevalence of hiv among adults aged 15 to 49 in Uruguay peaked at 0.6% in 2017 and was at its lowest, 0.3%, in 2000.
That places Uruguay 55th out of 143 countries with data for 2025, putting it in the middle of the range.
The long-run direction has been consistently rising across the 26 years of available data.
Prevalence of HIV among adults aged 15 to 49 in Uruguay, year by year
| Year | Value | Change |
|---|---|---|
| 2000 | 0.3% | — |
| 2001 | 0.3% | +0.0% |
| 2002 | 0.3% | +0.0% |
| 2003 | 0.3% | +0.0% |
| 2004 | 0.3% | +0.0% |
| 2005 | 0.4% | +33.3% |
| 2006 | 0.4% | +0.0% |
| 2007 | 0.4% | +0.0% |
| 2008 | 0.4% | +0.0% |
| 2009 | 0.4% | +0.0% |
| 2010 | 0.5% | +25.0% |
| 2011 | 0.5% | +0.0% |
| 2012 | 0.5% | +0.0% |
| 2013 | 0.5% | +0.0% |
| 2014 | 0.5% | +0.0% |
| 2015 | 0.5% | +0.0% |
| 2016 | 0.5% | +0.0% |
| 2017 | 0.6% | +20.0% |
| 2018 | 0.6% | +0.0% |
| 2019 | 0.6% | +0.0% |
| 2020 | 0.6% | +0.0% |
| 2021 | 0.6% | +0.0% |
| 2022 | 0.6% | +0.0% |
| 2023 | 0.6% | +0.0% |
| 2024 | 0.6% | +0.0% |
| 2025 | 0.6% | +0.0% |
Uruguay compared with similar countries
- Uruguay's 0.6% is above the median for high income countries, which is 0.2%, 3.0× the median. (42 countries reporting)
- Uruguay's 0.6% is below the median for Latin America & Caribbean, which is 0.7%, 86% of the median. (27 countries reporting)
Averages by decade
| Decade | Average | Lowest | Highest | Years |
|---|---|---|---|---|
| 2000s | 0.3% | 0.3% | 0.4% | 10 |
| 2010s | 0.5% | 0.5% | 0.6% | 10 |
| 2020s | 0.6% | 0.6% | 0.6% | 6 |
Countries ranked near Uruguay
More health data for Uruguay
- Un projection of annual infant deaths, annual growth rate 0 % change on previous year (2100)
- Heat deaths vs projected death rates, annual growth rate 0.6727 % change on previous year (2090)
- Estimated changes in temperature-related death rates compared to projected death rates 1,631 deaths per 1,000 people (2090)
- Number of infants who die before age 1 31 deaths (2100)
- Neonatal tetanus - number of reported cases, gaps filled 0 (2025)
- Population ages 00-04, female, annual growth rate -1.79 % change on previous year (2025)
- Population ages 00-04, female, per unit of GDP 0 units per US$ of GDP (2025)
- Population ages 00-04, female, per capita 0.0241 units per person (2025)
- Population ages 00-04, male, annual growth rate -1.84 % change on previous year (2025)
- Population ages 00-04, male, per unit of GDP 0 units per US$ of GDP (2025)
Frequently asked questions
- What is prevalence of hiv among adults aged 15 to 49 in Uruguay?
- Prevalence of hiv among adults aged 15 to 49 in Uruguay was 0.6% in 2025, according to World Health Organization, Global Health Observatory.
- What is the highest prevalence of hiv among adults aged 15 to 49 recorded in Uruguay?
- The highest recorded value was 0.6% in 2017.
- What is the lowest prevalence of hiv among adults aged 15 to 49 recorded in Uruguay?
- The lowest recorded value was 0.3% in 2000.
- How does Uruguay rank for prevalence of hiv among adults aged 15 to 49?
- Uruguay ranks 55th out of 143 countries with data for 2025.
- Is prevalence of hiv among adults aged 15 to 49 rising or falling in Uruguay?
- Over the last ten years it is up 20.0%. The long-run trend across the full record is rising.
- Where does this Uruguay data come from?
- The figures come from World Health Organization, Global Health Observatory, published as part of Prevalence of HIV among adults aged 15 to 49 (%). Statizoid updates them automatically from the source API.
Download this data
CSV · JSON — 26 observations, free to reuse under CC BY-NC-SA 3.0 IGO (WHO).